MANCHESTER, England (AP) — Manchester City’s players were booed by their own fans Tuesday after blowing a three-goal lead against Feyenoord in the Champions League to extend their winless run to six games. Jeers rang around the Etihad Stadium after the final whistle of a dramatic 3-3 draw. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Ian Schieffelin, Clemson topple Penn State to win Sunshine Slam
Man City blows 3-goal lead and gets booed by fans in draw with Feyenoord in Champions League
Georgetown is set to play its first road game of the season while West Virginia attempts to build off its successful 2-1 trip to the Bahamas when the former conference rivals meet on Friday in Morgantown, W. Va., as part of the Big 12-Big East Battle. Picked 13th out of 16 in the Big 12 preseason coaches' poll, West Virginia (5-2) has been riding the hot shooting of Javon Small and Tucker DeVries. Small averages a team-high 19 points and shoots 41.3 percent on 3-pointers while DeVries adds 14.9 points per game and hits on 46.9 percent of his threes. Every basket was needed last week as the Mountaineers upset then-No. 3 Gonzaga and then-No. 24 Arizona with a loss to Louisville sandwiched in between. All three contests went into overtime, believed to be a first in program history. First-year coach Darian DeVries, who led Drake to three NCAA Tournaments in the last four seasons, had never seen anything like it. "I've never been a part of three games like that, especially with the quality of opponents that we went up these last three days," he said after the Arizona win. "Just incredible resolve and grit and toughness from our group all three nights." Georgetown has started 7-1 for the first time since the 2018-19 season and has done so with a completely revamped roster that includes 14 freshmen or sophomores. As a result of an inexperienced squad, coach Ed Cooley specifically delayed the Hoyas' first trip out of the nation's capital. "Obviously, the competition is going to change," Cooley said after the Hoyas defeated UMBC 86-62 on Monday. "We systematically scheduled this way to build confidence, continuity and chemistry and let our players feel what it is to win, and that's something hopefully that will have some carryover as we now get ready to head out on the road for the first time." Since losing to Notre Dame on Nov. 16, Georgetown has won five straight games by an average of 25.2 points. Thomas Sorber leads the Hoyas in scoring at 15.8 points per game and leads the conference in rebounding at 8.9 per game. Sorber was named as the Big East Freshman of the Week for the third time in four weeks. Georgetown holds the narrowest of leads in the all-time series at 27-26. The two schools met 27 times between 1995 and 2012 as league foes. The Mountaineers captured their lone Big East Championship in 2010 by defeating the Hoyas 60-58 at Madison Square Garden. --Field Level MediaFRANKFORT, Ky. (AP) — Looking for hard-to-find bottles of Kentucky bourbon to toast the holidays or add to a collection? Get your bids ready as the Bluegrass State launches its first online auction of confiscated alcohol. Whiskeys up for sale include two bottles of Old Rip Van Winkle, a Blanton’s Single Barrel Gold in box with Japanese markings and a bottle of Four Roses Small Batch Barrel Strength 2011. The sale is the result of a new Kentucky law, which allows alcohol confiscated from closed criminal investigations by the state's alcoholic beverage control agency to be auctioned. Online bidding opens Wednesday and closes at midnight on Dec. 11. Proceeds will support programs promoting responsible alcohol use by adults and awareness programs for youths. “This is a really good auction,” Eric Gregory, president of the Kentucky Distillers’ Association, said by phone Tuesday. “There are some hard-to-find and rare bottles on there.” No estimate has been given on how much the auction might raise. “We look forward to seeing the response to this auction and have started planning additional auctions for 2025,” said Allyson Taylor, commissioner of the Kentucky Department of Alcoholic Beverage Control. The auction features 32 bottles of alcohol and includes a “stock the bar” bundle with bottles of wine, vodka, rum and whiskey, the agency said. But the stars are the hard-to-find and rare bourbons up for sale. “It’s not every day you go to a liquor store and find a bottle of Blanton’s Gold," Gregory said. “You never go to a liquor store and find a bottle of Four Roses 2011.” The lineup includes bottles of E.H. Taylor bourbon, Blanton’s Single Barrel, Eagle Rare 10 yr., Weller Antique 107, Willett Family Estate Single Barrel Rye, Michter’s, an Old Forester gift set and more. A link to the online auction is available at ABC.ky.gov . Auction items cannot be shipped, so winning bidders must pick up items in Frankfort, the state said. The auctions will become a “can't miss opportunity” for bourbon connoisseurs, Gregory said. Previously, confiscated bourbon or other spirits could end up being destroyed, he said. “We don't like to see good bourbon poured down the drain,” Gregory said. Kentucky distillers produce 95% of the global bourbon supply, the Kentucky distillers’ group says.
Medical Foam Market is Set to Grow at a CAGR of 6.9% During the Forecast Period by 2031 | Key Players- BASF SE, Huntsman International LLC, Recticel NVOtavio scores as Al Sadd hold Al Hilal to thrilling 1-1 draw
Ian Schieffelin, Clemson topple Penn State to win Sunshine SlamWalgreens Boots Alliance Inc. stock underperforms Tuesday when compared to competitors
Medical Foam Market is Set to Grow at a CAGR of 6.9% During the Forecast Period by 2031 | Key Players- BASF SE, Huntsman International LLC, Recticel NV 11-26-2024 07:04 PM CET | Advertising, Media Consulting, Marketing Research Press release from: DataM intelligence 4 Market Research LLP Medical Foam Market The Medical Foam Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Medical Foam market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth. Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://www.datamintelligence.com/download-sample/medical-foam-market Medical Foam Market is expected to grow at a CAGR of 6.9% during the forecast period 2024-2031. Medical foam refers to foam materials used in various medical applications, including wound care, orthopedic devices, and surgical procedures. These foams can be made from different materials and have specific properties to suit different needs. Key Developments: ❁ On March 10, 2022, Foamtec Medical created a novel foam formulation that is intended to collect the most sample volume and discharge the most. Currently the only company that formulates and produces medical-grade polyurethane foam on a fully integrated basis is Foamtec Medical. ❁ On June 30, 2022, Vanderbilt University scientists announced the development of a synthetic biodegradable foam that can reduce inflammation, encourage the growth of blood vessels and support the quick healing of chronic skin wounds. This discovery may one day enhance medical care for sick patients while also possibly lowering the costs of a significant global health issue. Competitive Landscape: The section also contains information related to the new product launches, mergers, acquisitions, collaborations, etc., to give a clear understanding about the competitive landscape prevailing in the global market. With an emphasis on strategies there have been several primary developments done by major companies such as BASF SE, Huntsman International LLC, Recticel NV, Foamtec Medical and General Plastics Manufacturing Company. Inc, Avery Dennison Corporation, Sekisui Chemicals Co. Ltd., Rogers Corporation, UFP Technologies INC, Zetefoams plc. Get Customization in the report as per your requirements + Exclusive Bundle & Multi-User Discounts: https://www.datamintelligence.com/customize/medical-foam-market Market Segments: The detailed segmentation offered in the report will help customers get a clear idea about the market segments and the factors that will drive segmental growth. The Medical Foam market has been segmented By Type (Flexible, Rigid, Spray) By Material (Polymers, Latex, Metal, Others) By Application (Bedding and Cushioning, Medical Devices and Components, Medical Packaging, Prosthetics and Wound Care, Others) Research Process: Both primary and secondary data sources have been used in the global Medical Foam Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges. Regional Outline for Medical Foam Market: ⇥ North America (U.S., Canada, Mexico) ⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe) ⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific) ⇥ South America (Colombia, Brazil, Argentina, Rest of South America) ⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa) **The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted** This Report Covers: ✔ Go-to-market Strategy. ✔ Neutral perspective on the market performance. ✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status. ✔Customized regional/country reports as per request and country level analysis. ✔ Potential & niche segments and regions exhibiting promising growth covered. ✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer). Chapter Outline: ⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Medical Foam market segments, study objectives, and years considered. ⏩ Market Landscape: The competition in the Global Medical Foam Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies. ⏩ Companies Profiles: The global Medical Foam market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production. ⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study. ⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Medical Foam Market. ⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type. ⏩ Research Findings: This section of the report showcases the findings and analysis of the report. ⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided. Unlock Year-End Savings! Get Up to 30% Off: https://www.datamintelligence.com/buy-now-page?report=medical-foam-market Frequently asked questions: ➠ What is the global sales value, production value, consumption value, import and export of Medical Foam market? ➠ Who are the global key manufacturers of the Medical Foam Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)? ➠ What are the Medical Foam market opportunities and threats faced by the vendors in the global Medical Foam Industry? ➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application? ➠ What focused approach and constraints are holding the Medical Foam market? ➠ What are the different sales, marketing, and distribution channels in the global industry? Contact Us - Company Name: DataM Intelligence Contact Person: Sai Kiran Email: Sai.k@datamintelligence.com Phone: +1 877 441 4866 Website: https://www.datamintelligence.com About Us - DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele. This release was published on openPR.SYDNEY, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Vast Renewables Limited (“Vast”) (Nasdaq: VSTE), a leading Australian green energy technology company, held its Annual General Meeting (“AGM”) on November 27, updating shareholders on progress towards deploying its next generation concentrated solar power (“CSP”) solution to deliver clean, continuous dispatchable power and heat. The AGM saw Vast’s Chairman, Peter Botten, and CEO, Craig Wood, provide updates on the company’s achievements throughout 2024 and the outlook for the year ahead. All resolutions were successfully passed at the AGM, with Craig Wood, Colin Richardson and William Restrepo all re-elected as Directors. The AGM follows Vast’s recent announcement that it has signed an updated funding agreement to access up to $30 million of its existing $65 million grant from the Australian Renewable Energy Agency (“ARENA”). The funding and Vast’s progress throughout 2024 pave the way for another successful year ahead. Vast’s technology is set to be deployed at utility-scale in Port Augusta, South Australia at the Vast Solar 1 (“VS1”) project to deliver green, reliable and affordable energy for South Australia’s grid. The technology will also power a world-first co-located renewable methanol production facility, Solar Methanol 1 (“SM1”). A real world, in-demand application for hydrogen, renewable methanol has the potential to decarbonise shipping and is already being used to power major container vessels. Leveraging Australia’s natural resources, the projects are set to be a catalyst for a domestic Australian CSP industry, creating highly skilled green manufacturing and operational jobs, and helping Australia become an export powerhouse by supplying Australian green technology to clean energy projects around the world. Vast is attracting significant interest from major investors, industry and international governments. Along with funding from ARENA, Vast is backed by EDF and Nabors Industries, and Vast’s renewable methanol project is supported by Mabanaft and the German Government. The following addresses were made by Vast’s Chairman Peter Botten and CEO Craig Wood during Vast’s Annual General Meeting on November 27, 2024. Chairman’s Address from Peter Botten 2024 has been a pivotal year in the growth of Vast since the business combination with Nabors Energy Transition Corp was completed in December last year. Significant progress has been made this year towards Vast’s vision of delivering continuous, carbon free energy to the world, leveraging our next generation CSP technology As announced earlier this week, Vast has secured up to $30m of funding from ARENA. This is an important signal of confidence from ARENA in the potential of Vast’s technology to power Australia’s energy transition, and we’re grateful for their ongoing support. Vast continues to progress towards final investment decision on our utility-scale CSP reference project in Port Augusta, South Australia (VS1). The project paves the way for Vast’s pipeline of utility-scale projects in Australia and internationally. Alongside generating green electricity for the grid, we believe Vast’s technology will have a key role to play in reducing the cost of sustainable fuels production. Vast is also progressing a co-located renewable methanol production facility (SM1) at the Port Augusta site, partnering with German fuels giant Mabanaft on that project. During the year, Vast also expanded its presence in the US market, signing a project development partnership with Houston-based renewables developer GGS Energy. As Vast looks to 2025, the key focus will be on: We continue to see growing demand for the continuous, affordable electricity and heat our CSP technology can deliver. We believe it will be a critical solution to decarbonise the grid and phase out coal in sunny countries. We also see continued demand for our technology to power sustainable fuels production as well as off-grid use cases, including mining, industrial processes and data centres. CEO’s Address from Craig Wood As Peter mentioned, our utility-scale CSP reference project in Port Augusta, VS1, is progressing well. The plant will have 30MW capacity and 8 hours of thermal storage, providing dispatchable overnight power critical to stabilising South Australia’s grid. We recently finalised the FEED stage and we’re working diligently with our partners towards achieving Final Investment Decision in Q1 2025 with construction to commence shortly thereafter. The project has received support from the Australian Government, including from ARENA and the Department for Climate Change, Energy, Environment and Water. The co-located renewable methanol plant, SM1, is also progressing well through the pre-FEED stage. The project will produce 7,500 tonnes of renewable methanol per annum, which will help decarbonise the local maritime industry. As a world-first project, we’re thrilled to be partnering with German company Mabanaft on this effort. Financial close is currently targeted for 2025. Vast continues to strengthen our market-leading proprietary CSP technology, and to build out our manufacturing capability ahead of delivering Vast equipment into the VS1 project. Our solution leverages the abundant sunshine in sunbelt countries like Australia to power homes, industry and transport with green, reliable and affordable energy. We continue to improve the cost and performance of our modular, scalable technology, and to de-risk its manufacture and operation. Vast equipment is currently being produced at our facility in Queensland, Australia, and we’ll be scaling up our manufacturing capability to deliver to the Port Augusta projects starting in 2025. Throughout 2024, we’ve also invested in our business systems and capabilities to set ourselves up for success. Vast has had a strong emphasis on safety during 2024, and we are focused on improving our safety performance as we head towards construction on site next year. We are investing in a new ERP to replace legacy systems as our requirements continue to evolve. We are also developing the quality and project control systems necessary to deliver the Port Augusta projects. All of this activity means Vast’s team has continued to grow throughout the year, both in Australia and the US. This growth will continue early into 2025, and then accelerate as we move into construction of the VS1 and SM1 projects. As Peter mentioned, we were delighted to announce earlier this week that Vast continues to enjoy strong support from ARENA as evidenced by up to $30m of funding being made available to the business, subject to certain milestones being achieved. This funding is important as it creates a runway to support Vast in completing the necessary activities to achieve financial close on VS1 and SM1, and to continue the build out of our Australian green technology manufacturing business. As part of that release, we also updated the estimated capital cost for VS1 to AUD360-390million. We look forward to another successful year in 2025 as we move into construction on VS1 and SM1, deliver Vast technology through our manufacturing business, and expand our project development pipeline in Australia, the US and other global markets. We thank you, our shareholders, all of our partners and our employees for their ongoing support. About Vast Vast is a renewable energy company that has CSP systems to generate, store, and dispatch carbon-free, utility-scale electricity, industrial heat, or a combination to enable the production of sustainable fuels. Vast’s CSP v3.0 approach utilises a proprietary, modular sodium loop to efficiently capture and convert solar heat into these end products. On December 19, 2023, Vast listed on the Nasdaq under the ticker symbol “VSTE”, while remaining headquartered in Australia. Visit www.vast.energy for more information. Contacts For Investors: Caldwell Bailey ICR, Inc. VastIR@icrinc.com For US media: Matt Dallas ICR, Inc. VastPR@icrinc.com For Australian media: Nick Albrow Wilkinson Butler nick@wilkinsonbutler.com Forward Looking Statements The information included herein and in any oral statements made in connection herewith include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of present or historical fact included herein, regarding the Port Augusta project, Vast's future financial performance, Vast's strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. When used herein, including any oral statements made in connection herewith, the words "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "project," "should," "will," the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on Vast management's current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. Except as otherwise required by applicable law, Vast disclaims any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date hereof. Vast cautions you that these forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of Vast. These risks include, but are not limited to, general economic, financial, legal, political and business conditions and changes in domestic and foreign markets; Vast's ability to obtain financing on commercially acceptable terms or at all; Vast’s ability to manage growth; Vast's ability to execute its business plan, including the completion of the Port Augusta project , at all or in a timely manner and meet its projections; potential litigation, governmental or regulatory proceedings, investigations or inquiries involving Vast, including in relation to Vast's recent business combination; the inability to recognize the anticipated benefits of Vast's recent business combination; costs related to that business combination; changes in applicable laws or regulations and general economic and market conditions impacting demand for Vast's products and services. Additional risks are set forth in the section titled "Risk Factors" in the Annual Report on Form 20-F for the year ended June 30, 2024, dated September 9, 2024, as amended on November 7, 2024, and other documents filed, or to be filed with the SEC by Vast. Should one or more of the risks or uncertainties described herein and in any oral statements made in connection therewith occur, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. Additional information concerning these and other factors that may impact Vast's expectations can be found in Vast's periodic filings with the SEC. Vast's SEC filings are available publicly on the SEC's website at www.sec.govThe COVID-19 pandemic has been over for years. The damage caused by the disease itself – and the economic shutdowns, mandated social isolation, and protracted school closures enacted in response – has been done. Many Americans want to leave the pandemic behind them. But it would be a grave mistake to simply move on before those responsible for lying about the pandemic, from their certainty of its origin in a Chinese wet market to their denials that the United States funded dangerous experiments that likely created the disease in the first place, are held accountable. That’s why, despite being overshadowed by other major news, including the Hunter Biden pardon, the sweeping 520-page report released this week by the U.S. House Select Committee on the Coronavirus Pandemic deserves serious attention. Among the most notable findings was the fact that Dr. Ashish K. Jha, the Biden-Harris administration’s COVID-19 response coordinator, admitted to the subcommittee last month that “COVID-19 virus might have accidentally leaked from a lab,” an acknowledgment of a reality that the medical establishment and corporate media long claimed was a “conspiracy theory” that had been “debunked.” Dr. Tim Specter, whom the subcommittee report notes “played a significant role in the pandemic response in the United Kingdom,” was more blunt than Dr. Jha. “It’s looking increasingly like that was a bit of a cover-up, and the most likely source of this was a lab leak from Wuhan,” he said, according to the report. And former Director of National Intelligence John Ratcliffe told the committee that “the ledger on the side of lab leak is full of convincing evidence, while the spillover side is nearly empty,” according to a paraphrase of his remarks. Why were these facts obscured for so long? The theory that COVID-19 originated in a wet market was purportedly given iron-clad credence in a 2020 article titled “The proximal origin of SARS-CoV-2,” published in the scientific journal Nature. The findings were treated as gospel by the media and top medical officials throughout 2020 and 2021. But an investigative piece in The Intercept found that the primary authors of that article, Drs. Kristian G. Andersen and Andrew Rambaut, “misled Congress” about a multimillion-dollar federal grant they were seeking at the time. As we noted in a July 2023 editorial, the doctors “had a powerful incentive” to produce findings that would please Dr. Fauci “because he controlled the flow of federal research dollars.” This matters because, as the congressional subcommittee confirmed, the federal government funded the Wuhan lab where many experts now agree the virus likely originated . Dr. Fauci had every reason to avoid the likely truth of the lab-leak hypothesis, which would have turned him from the pandemic era’s valiant hero to its feckless villain overnight. Perhaps the most damning line in the subcommittee’s report: “When Dr. Andersen presented a draft of (“The proximal origin of SARS-CoV-2′′) to Nature, he stated it was ‘prompted’ by Dr. Fauci and later stated the goal of (the article) was to ‘disprove the lab leak theory.'” If there was ever an inconvenient truth, it’s the fact that millions of people were killed by, and billions of dollars were spent to mitigate the effects of, a virus whose likely origin was covered up solely for the benefit of well-compensated and unduly-venerated federal employees.
Lindsay Lohan reveals how she regained her 'sparkle'
Operations teams have confirmed NASA’s mission to “touch” the Sun survived its record-breaking closest approach to the solar surface on Dec. 24, 2024. Breaking its previous record by flying just 3.8 million miles above the surface of the Sun, NASA’s Parker Solar Probe hurtled through the solar atmosphere at a blazing 430,000 miles per hour — faster than any human-made object has ever moved. A beacon tone received late on Dec. 26 confirmed the spacecraft had made it through the encounter safely and is operating normally. This pass, the first of more to come at this distance, allows the spacecraft to conduct unrivaled scientific measurements with the potential to change our understanding of the Sun. “Flying this close to the Sun is a historic moment in humanity’s first mission to a star,” said Nicky Fox, who leads the Science Mission Directorate at NASA Headquarters in Washington. “By studying the Sun up close, we can better understand its impacts throughout our solar system, including on the technology we use daily on Earth and in space, as well as learn about the workings of stars across the universe to aid in our search for habitable worlds beyond our home planet.” Parker Solar Probe has spent the last six years setting up for this moment. Launched in 2018, the spacecraft used seven flybys of Venus to gravitationally direct it ever closer to the Sun. With its last Venus flyby on Nov. 6, 2024, the spacecraft reached its optimal orbit. This oval-shaped orbit brings the spacecraft an ideal distance from the Sun every three months — close enough to study our Sun’s mysterious processes but not too close to become overwhelmed by the Sun’s heat and damaging radiation. The spacecraft will remain in this orbit for the remainder of its primary mission. “Parker Solar Probe is braving one of the most extreme environments in space and exceeding all expectations,” said Nour Rawafi, the project scientist for Parker Solar Probe at the Johns Hopkins Applied Physics Laboratory (APL), which designed, built, and operates the spacecraft from its campus in Laurel, Maryland. “This mission is ushering a new golden era of space exploration, bringing us closer than ever to unlocking the Sun’s deepest and most enduring mysteries.” Close to the Sun, the spacecraft relies on a carbon foam shield to protect it from the extreme heat in the upper solar atmosphere called the corona, which can exceed 1 million degrees Fahrenheit. The shield was designed to reach temperatures of 2,600 degrees Fahrenheit — hot enough to melt steel — while keeping the instruments behind it shaded at a comfortable room temperature. In the hot but low-density corona, the spacecraft’s shield is expected to warm to 1,800 degrees Fahrenheit. “It’s monumental to be able to get a spacecraft this close to the Sun,” said John Wirzburger, the Parker Solar Probe mission systems engineer at APL. “This is a challenge the space science community has wanted to tackle since 1958 and had spent decades advancing the technology to make it possible.” By flying through the solar corona, Parker Solar Probe can take measurements that help scientists better understand how the region gets so hot, trace the origin of the solar wind (a constant flow of material escaping the Sun), and discover how energetic particles are accelerated to half the speed of light. “The data is so important for the science community because it gives us another vantage point,” said Kelly Korreck, a program scientist at NASA Headquarters and heliophysicist who worked on one of the mission’s instruments. “By getting firsthand accounts of what’s happening in the solar atmosphere, Parker Solar Probe has revolutionized our understanding of the Sun.” Previous passes have already aided scientists’ understanding of the Sun. When the spacecraft first passed into the solar atmosphere in 2021, it found the outer boundary of the corona is wrinkled with spikes and valleys, contrary to what was expected. Parker Solar Probe also pinpointed the origin of important zig-zag-shaped structures in the solar wind, called switchbacks, at the visible surface of the Sun — the photosphere. Since that initial pass into the Sun, the spacecraft has been spending more time in the corona, where most of the critical physical processes occur. “We now understand the solar wind and its acceleration away from the Sun,” said Adam Szabo, the Parker Solar Probe mission scientist at NASA’s Goddard Space Flight Center in Greenbelt, Maryland. “This close approach will give us more data to understand how it’s accelerated closer in.” Parker Solar Probe has also made discoveries across the inner solar system. Observations showed how giant solar explosions called coronal mass ejections vacuum up dust as they sweep across the solar system, and other observations revealed unexpected findings about solar energetic particles. Flybys of Venus have documented the planet’s natural radio emissions from its atmosphere, as well as the first complete image of its orbital dust ring. So far, the spacecraft has only transmitted that it’s safe, but soon it will be in a location that will allow it to downlink the data it collected on this latest solar pass. “The data that will come down from the spacecraft will be fresh information about a place that we, as humanity, have never been,” said Joe Westlake, the director of the Heliophysics Division at NASA Headquarters. “It’s an amazing accomplishment.” The spacecraft’s next planned close solar passes come on March 22, 2025, and June 19, 2025. By Mara Johnson-Groh Astrobiology, Space Weather, Heliophysics,
